Silverarc Capital Management, LLC Portfolio Holdings

Silverarc Capital Management, LLC

  • $411 Million
  • Q1 2025

Silverarc Capital Management, LLC has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $411 Million distributed in 69 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $34.7M, Merus N.V. with a value of $34.1M, Nuvalent, Inc. with a value of $31.1M, Akero Therapeutics, Inc. with a value of $29.1M, and Insmed Inc with a value of $24.5M.

Examining the 13F form we can see an decrease of $5.19M in the current position value, from $416M to 411M.

Below you can find more details about Silverarc Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $411 Million
Healthcare: $411 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$5.58B
$34.7 Million 8.44% of portfolio
545,872
Q1 2025 Added 5.79%
$2.47B
$34.1 Million 8.31% of portfolio
811,021
Q1 2025 Added 19.12%
$3.46B
$31.1 Million 7.58% of portfolio
439,018
Q1 2025 Added 9.75%
$2.4B
$29.1 Million 7.1% of portfolio
719,992
Q1 2025 Reduced 2.65%
$13.2B
$24.5 Million 5.97% of portfolio
321,366
Q1 2025 Reduced 13.66%
$295M
$19.6 Million 4.78% of portfolio
1,698,984
Q1 2025 Added 177.53%
$1.97B
$18.8 Million 4.58% of portfolio
633,832
Q1 2025 Added 25.94%
$3.66B
$17.9 Million 4.36% of portfolio
337,605
Q1 2025 Added 23.26%
$509M
$16.1 Million 3.92% of portfolio
1,309,224
Q1 2025 Added 6.41%
$309M
$15.3 Million 3.72% of portfolio
1,381,158
Q1 2025 Added 23.27%
$1.52B
$12.1 Million 2.96% of portfolio
411,312
Q1 2025 Reduced 24.34%
$9.72B
$11.8 Million 2.88% of portfolio
75,751
Q1 2025 Added 47.12%
$427M
$11.5 Million 2.8% of portfolio
2,060,240
Q1 2025 Added 74.85%
$472M
$11 Million 2.67% of portfolio
1,510,498
Q1 2025 Added 1,465.1%
$176M
$10.1 Million 2.46% of portfolio
7,367,996
Q1 2025 Reduced 2.33%
$603M
$8.49 Million 2.07% of portfolio
1,050,374
Q1 2025 Added 72.5%
$963M
$7.33 Million 1.78% of portfolio
408,849
Q1 2025 Added 47.4%
$117M
$6.95 Million 1.69% of portfolio
6,320,684
Q1 2025 Added 2.41%
$140B
$6.95 Million 1.69% of portfolio
62,029
Q1 2025 Added 520.29%
$152M
$4.23 Million 1.03% of portfolio
2,895,430
Q1 2025 Added 78.25%
$1.1B
$4.18 Million 1.02% of portfolio
81,331
Q1 2025 Added 23.31%
$4.74B
$4.12 Million 1.0% of portfolio
124,871
Q1 2025 New
$740M
$4.04 Million 0.98% of portfolio
551,570
Q1 2025 New
$13.5M
$3.87 Million 0.94% of portfolio
2,670,056
Q1 2025 Added 49.81%
$6.52B
$3.84 Million 0.93% of portfolio
111,000
Q1 2025 New
$392M
$3.84 Million 0.93% of portfolio
581,369
Q1 2025 New
$1.03B
$3.74 Million 0.91% of portfolio
205,962
Q1 2025 Reduced 22.15%
$273M
$3.41 Million 0.83% of portfolio
2,456,537
Q1 2025 Added 54.77%
$5.11B
$3.43 Million 0.83% of portfolio
10,344
Q1 2025 New
$1.33B
$3.35 Million 0.82% of portfolio
232,758
Q1 2025 Reduced 61.14%
$39.1M
$3.38 Million 0.82% of portfolio
2,771,288
Q1 2025 Reduced 9.6%
$347M
$3.33 Million 0.81% of portfolio
530,000
Q1 2025 Reduced 27.82%
$7.67B
$3.31 Million 0.81% of portfolio
37,345
Q1 2025 New
$785M
$3.16 Million 0.77% of portfolio
214,057
Q1 2025 New
$3.51B
$3.08 Million 0.75% of portfolio
60,389
Q1 2025 New
$10.8M
$2.58 Million 0.63% of portfolio
4,098,406
Q1 2025 Reduced 5.4%
$109M
$2.44 Million 0.59% of portfolio
191,470
Q1 2025 Added 23.27%
$674M
$2.16 Million 0.53% of portfolio
203,400
Q1 2025 Added 103.4%
$282M
$1.66 Million 0.4% of portfolio
874,869
Q1 2025 New
$72.4M
$1.41 Million 0.34% of portfolio
882,300
Q1 2025 Reduced 27.75%
$69.2M
$1.38 Million 0.33% of portfolio
2,413,489
Q1 2025 Reduced 2.94%
$206M
$1.24 Million 0.3% of portfolio
441,807
Q1 2025 Reduced 55.82%
$35.4M
$1.18 Million 0.29% of portfolio
1,161,567
Q1 2025 New
$28.2M
$1.05 Million 0.26% of portfolio
3,088,505
Q1 2025 New
$7.97M
$1.05 Million 0.25% of portfolio
958,881
Q1 2025 Reduced 24.62%
$2.07B
$339,000 0.08% of portfolio
10,121
Q1 2025 New
$54.4M
$280,000 0.07% of portfolio
683,825
Q1 2025 Reduced 36.55%
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Benitec Biopharma Inc
-
$0 0.0% of portfolio
-
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 69
  • Current Value $411 Million
  • Prior Value $416 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 14, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 23 stocks
  • Additional Purchases 27 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 15 stocks
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email